Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin.
Nicotinamide/nicotinate mononucleotide (NMN/ NaMN)adenylyltransferase (NMNAT) is an indispensable enzyme in the biosynthesis of NAD(+) and NADP(+). Human NMNAT displays unique dual substrate specificity toward both NMN and NaMN, thus flexible in participating in both de novo and salvage pathways of NAD synthesis. Human NMNAT also catalyzes the rate-limiting step of the metabolic conversion of the anticancer agent tiazofurin to its active form tiazofurin adenine dinucleotide (TAD). The tiazofurin resistance is mainly associated with the low NMNAT activity in the cell. We have solved the crystal structures of human NMNAT in complex with NAD, deamido-NAD, and a non-hydrolyzable TAD analogue beta-CH(2)-TAD. These complex structures delineate the broad substrate specificity of the enzyme toward both NMN and NaMN and reveal the structural mechanism for adenylation of tiazofurin nucleotide. The crystal structure of human NMNAT also shows that it forms a barrel-like hexamer with the predicted nuclear localization signal sequence located on the outside surface of the barrel, supporting its functional role of interacting with the nuclear transporting proteins. The results from the analytical ultracentrifugation studies are consistent with the formation of a hexamer in solution under certain conditions.
Zhou
Tianjun
T
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Kurnasov
Oleg
O
Tomchick
Diana R
DR
Binns
Derk D
DD
Grishin
Nick V
NV
Marquez
Victor E
VE
Osterman
Andrei L
AL
Zhang
Hong
H
D000595:Amino Acid Sequence; D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D001665:Binding Sites; D001711:Biotransformation; D002384:Catalysis; D006801:Humans; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009612:Nicotinamide-Nucleotide Adenylyltransferase / Q000737:chemistry / Q000378:metabolism*; D011487:Protein Conformation; D012254:Ribavirin / Q000031:analogs & derivatives / Q000493:pharmacokinetics*; D017386:Sequence Homology, Amino Acid; D013379:Substrate Specificity
D000970:Antineoplastic Agents; D012254:Ribavirin; D009612:Nicotinamide-Nucleotide Adenylyltransferase; C033706:tiazofurin